The heterogeneity of ovarian cancer

被引：72

作者：

Meinhold-Heerlein, I. ^{[1
,2
]}

Hauptmann, S. ^{[1
,2
]}

机构：

[1] Univ Hosp Aachen, Dept Gynecol & Obstet, D-52074 Aachen, Germany

[2] Hosp Duren, Inst Pathol, Duren, Germany

来源：

ARCHIVES OF GYNECOLOGY AND OBSTETRICS | 2014年 / 289卷 / 02期

关键词：

Ovarian cancer; Heterogeneity; Borderline tumors of the ovary; Pathogenesis; BORDERLINE TUMORS; PATHOGENESIS;

D O I：

10.1007/s00404-013-3114-3

中图分类号：

R71 [妇产科学];

学科分类号：

100211 ;

摘要：

Ovarian cancer carries the worst prognosis of all gynecological malignancies. This is mainly due to its resistance against commonly used cytostatic drugs as well as the lack of a screening method for its detection at an early stage. Both basic and translational research have shown over the past decades that ovarian cancer as a medical term includes several types of tumors with different phenotypes, molecular biology, etiology, tumor progression, and even different prognosis. In this issue of Archives of Gynecology and Obstetrics, J. Dietel presents a review article about novel findings of the etiopathogenesis of ovarian cancer and the role that fallopian tubes may play. He also outlines the implied clinical consequences. Here, we give a brief overview of the heterogeneity of ovarian cancer to introduce the topic.

引用

页码：237 / 239

页数：3

共 13 条

[1] The role of p53 as a surrogate marker for chemotherapeutical responsiveness in ovarian cancer [J].

Bauerschlag, Dirk O. ;

Schem, Christian ;

Weigel, Marion T. ;

von Kaisenberg, Constantin ;

Strauss, Alexander ;

Bauknecht, Thomas ;

Maass, Nicolai ;

Meinhold-Heerlein, Ivo .

JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2010, 136 (01) :79-88

[2] Borderline Tumors of the Ovary - A Systematic Review [J].

du Bois, A. ;

Ewald-Riegler, N. ;

du Bois, O. ;

Harter, P. .

GEBURTSHILFE UND FRAUENHEILKUNDE, 2009, 69 (09) :807-833

[3] Incessant ovulation, inflammation and epithelial ovarian carcinogenesis:: Revisiting old hypotheses [J].

Fleming, JS ;

Beaugié, CR ;

Haviv, I ;

Chenevix-Trench, G ;

Tan, OL .

MOLECULAR AND CELLULAR ENDOCRINOLOGY, 2006, 247 (1-2) :4-21

[4] Genetic alterations in epithelial ovarian tumors analyzed by comparative genomic hybridization [J].

Hauptmann, S ;

Denkert, C ;

Koch, I ;

Petersen, S ;

Schlüns, K ;

Reles, A ;

Dietel, M ;

Petersen, I .

HUMAN PATHOLOGY, 2002, 33 (06) :632-641

[5] Carcinoma of the ovary [J].

Heintz, A. P. M. ;

Odicino, F. ;

Maisonneuve, P. ;

Quinn, M. A. ;

Benedet, J. L. ;

Creasman, W. T. ;

Ngan, H. Y. S. ;

Pecorelli, S. ;

Beller, U. .

INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 2006, 95 :S161-S192

[6] Ovarian cancer [J].

Hennessy, Bryan T. ;

Coleman, Robert L. ;

Markman, Maurie .

LANCET, 2009, 374 (9698) :1371-1382

[7] Molecular profiles of hereditary epithelial ovarian cancers and their implications for the biology of this disease [J].

Jazaeri, Amir A. .

MOLECULAR ONCOLOGY, 2009, 3 (02) :151-156

[8] Pathogenesis of ovarian cancer: Lessons from morphology and molecular biology and their clinical implications [J].

Kurman, Robert J. ;

Shih, Ie-Ming .

INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY, 2008, 27 (02) :151-160

[9] The Origin and Pathogenesis of Epithelial Ovarian Cancer: A Proposed Unifying Theory [J].

Kurman, Robert J. ;

Shih, Ie-Ming .

AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2010, 34 (03) :433-443

[10] Molecular and prognostic distinction between serous ovarian carcinomas of varying grade and malignant potential [J].

Meinhold-Heerlein, I ;

Bauerschlag, D ;

Hilpert, F ;

Dimitrov, P ;

Sapinoso, LM ;

Orlowska-Volk, M ;

Bauknecht, T ;

Park, TW ;

Jonat, W ;

Jacobsen, A ;

Sehouli, J ;

Luttges, J ;

Krajewski, M ;

Krajewski, S ;

Reed, JC ;

Arnold, N ;

Hampton, GM .

ONCOGENE, 2005, 24 (06) :1053-1065

← 1 2 →